Evidence map›Paper›PMID 30044648›Full record

ReviewAnnual review of cell and developmental biology2018

Intercellular Spread of Protein Aggregates in Neurodegenerative Disease.

Albert A Davis, Cheryl E G Leyns, David M Holtzman

Abstract readReview
In one paragraph

Review in Annual review of cell and developmental biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Transdiagnostic prevention in youth mental health, Part I: rationale, shared risk factors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  9. Review
  10. Current Understanding of Protein Aggregation in Neurodegenerative Diseases.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Albert A DavisDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA; email: holtzman@wustl.edu.
Cheryl E G LeynsDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA; email: holtzman@wustl.edu.
David M HoltzmanDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA; email: holtzman@wustl.edu.

Funding

ApoE Regulation of Alpha-Synuclein Pathology in Parkinson Disease DementiaK08NS101118 · NINDS · WASHINGTON UNIVERSITY · PI DAVIS, ALBERT A · 2017 to 2021
$859k
NINDS NIH HHS K08 NS101118
6 · The paper itself

Abstract

Most neurodegenerative diseases are characterized by the accumulation of protein aggregates, some of which are toxic to cells. Mounting evidence demonstrates that in several diseases, protein aggregates can pass from neuron to neuron along connected networks, although the role of this spreading phenomenon in disease pathogenesis is not completely understood. Here we briefly review the molecular and histopathological features of protein aggregation in neurodegenerative disease, we summarize the evidence for release of proteins from donor cells into the extracellular space, and we highlight some other mechanisms by which protein aggregates might be transmitted to recipient cells. We also discuss the evidence that supports a role for spreading of protein aggregates in neurodegenerative disease pathogenesis and some limitations of this model. Finally, we consider potential therapeutic strategies to target spreading of protein aggregates in the treatment of neurodegenerative diseases.

Indexed as

Alzheimer DiseaseAmyotrophic Lateral SclerosisChronic Traumatic EncephalopathyFrontotemporal DementiaHumansHuntington DiseaseNeurodegenerative DiseasesNeuronsParkinson DiseasePrion DiseasesProtein AggregatesProtein Aggregation, PathologicalProtein Aggregatesneurodegenerative diseaseprotein aggregateseedingspreading

Identifiers

PMID30044648
PMCPMC6350082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.